Publication:
sRNA/L1 retrotransposition: using siRNAs and miRNAs to expand the applications of the cell culture-based LINE-1 retrotransposition assay.

dc.contributor.authorTristan-Ramos, Pablo
dc.contributor.authorMorell, Santiago
dc.contributor.authorSanchez, Laura
dc.contributor.authorToledo, Belen
dc.contributor.authorGarcia-Perez, Jose L
dc.contributor.authorHeras, Sara R
dc.date.accessioned2023-02-08T14:41:38Z
dc.date.available2023-02-08T14:41:38Z
dc.date.issued2020-02-10
dc.description.abstractThe cell culture-based retrotransposition reporter assay has been (and is) an essential tool for the study of vertebrate Long INterspersed Elements (LINEs). Developed more than 20 years ago, this assay has been instrumental in characterizing the role of LINE-encoded proteins in retrotransposition, understanding how ribonucleoprotein particles are formed, how host factors regulate LINE mobilization, etc. Moreover, variations of the conventional assay have been developed to investigate the biology of other currently active human retrotransposons, such as Alu and SVA. Here, we describe a protocol that allows combination of the conventional cell culture-based LINE-1 retrotransposition reporter assay with short interfering RNAs (siRNAs) and microRNA (miRNAs) mimics or inhibitors, which has allowed us to uncover specific miRNAs and host factors that regulate retrotransposition. The protocol described here is highly reproducible, quantitative, robust and flexible, and allows the study of several small RNA classes and various retrotransposons. To illustrate its utility, here we show that siRNAs to Fanconi anaemia proteins (FANC-A and FANC-C) and an inhibitor of miRNA-20 upregulate and downregulate human L1 retrotransposition, respectively. This article is part of a discussion meeting issue 'Crossroads between transposons and gene regulation'.
dc.identifier.doi10.1098/rstb.2019.0346
dc.identifier.essn1471-2970
dc.identifier.pmcPMC7061984
dc.identifier.pmid32075559
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061984/pdf
dc.identifier.unpaywallURLhttps://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2019.0346
dc.identifier.urihttp://hdl.handle.net/10668/15131
dc.issue.number1795
dc.journal.titlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences
dc.journal.titleabbreviationPhilos Trans R Soc Lond B Biol Sci
dc.language.isoen
dc.organizationCentro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO
dc.page.number20190346
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectFanconi anaemia
dc.subjectLINE-1
dc.subjectcell culture-based retrotransposition reporter assay
dc.subjectmiR-20
dc.subjectmiRNAs
dc.subjectsiRNAs
dc.subject.meshCell Culture Techniques
dc.subject.meshGenetic Techniques
dc.subject.meshLong Interspersed Nucleotide Elements
dc.subject.meshMicroRNAs
dc.subject.meshRNA, Small Interfering
dc.subject.meshRetroelements
dc.titlesRNA/L1 retrotransposition: using siRNAs and miRNAs to expand the applications of the cell culture-based LINE-1 retrotransposition assay.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number375
dspace.entity.typePublication

Files